Aprea Therapeutics, Inc.
APRE
Revenue
0.00
0.000.00%
-Assets
23.98M
▼-2.91M▼-10.84%
3 Months ChangeLiabilities
3.95M
▼-276.57k▼-6.54%
3 Months ChangeFree Cash Flow
-3.94M
▲3.61M▲47.79%
48 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-23
Form 8-K
ID: 0001558370-24-013486
2024-10-09
Form 8-K
ID: 0001104659-24-107219
2024-08-12
Form 8-K
ID: 0001558370-24-011808
2024-08-12
Form 10-Q
ID: 0001558370-24-011806
2024-06-20
Form 8-K
ID: 0001104659-24-073396
2024-06-17
Form 8-K
ID: 0001558370-24-009225
2024-05-14
Form 8-K
ID: 0001558370-24-008070
2024-05-14
Form 10-Q
ID: 0001558370-24-008069
2024-04-10
Form 8-K
ID: 0001558370-24-004927
2024-03-26
Form 8-K
ID: 0001558370-24-003887